Healthcare Data Interoperability Market Size & Share 2023 to 2032
Market Size by Level (Foundational, Structural, Semantic), by Deployment (Cloud-based, On-premise) by Application (Diagnosis, Treatment), by Model (Centralized, Hybrid, Decentralized) by End Use & Global Forecast.
Report ID: GMI3148
|
Published Date: April 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Healthcare Data Interoperability Market Size
Healthcare Data Interoperability Market size was valued at over USD 5.5 billion in 2022 and is poised to grow at over 13% CAGR through 2023 - 2032. Driven by rising global healthcare expenditure.
Healthcare Data Interoperability Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Surging healthcare investments across both developed and developing economies have helped many healthcare organizations afford advanced interoperability software for effective management of healthcare data. As per Centers for Medicare & Medicaid Services, in 2021, U.S. healthcare spending grew by 2.7%, hitting USD 4.3 trillion, which accounts for 18.3% of the country’s GDP.
Steep cost of healthcare data interoperability software may constrain industry progression
Despite ample growth opportunities, high professional service charges, expansive software maintenance costs and license fees add to the overall cost of product. The involved costs can also go up depending on different types of interfacing capability options. In fact, in the first year of installation, costs related to software development and infrastructure to ensure interoperability within a healthcare organization can exceed USD 60,000.
Additionally, data transfer from one healthcare software to another requires at least two vendors, which doubles the transfer charges, making the service out of reach for many small and medium-scale healthcare enterprises.
Healthcare Data Interoperability Market Analysis
In terms of level, healthcare data interoperability market from the structural segment is anticipated to record a valuation of more than USD 7.5 billion by 2032. Structural interoperability level defines the data structure of information that is being transferred between systems. It allows uniform transfer of health data between systems while keeping its meaning intact. Additionally, it offers standardized message formatting which enables healthcare organizations to interpret data at the field level and helps them take effective clinical decisions to minimize the chances of adverse health events.
With respect to application, healthcare data interoperability market valuation from diagnosis segment is poised to surpass USD 9.9 billion by 2032. Diagnostic data helps healthcare organizations in getting meaningful insights into patient history, efficacy of surgical techniques, reinfection rates, and others which helps them take effective actions for further treatment.
Surging number of people undergoing diagnosis has bolstered the demand for healthcare data interoperability software for effective transfer of diagnostic data for better clinical outcomes. As per the American Cancer Society, around 1.9 million new cancer cases are poised to be diagnosed in 2023 in the U.S. alone.
From the regional perspective, North America healthcare data interoperability market held over 44% of the overall business share in 2022. Growing investments towards healthcare digitalization have hastened the demand for healthcare data interoperability software in the region. In fact, in June 2022, the government of Manitoba, a province in Canada that borders Ontario, invested more than USD 7 million to improve virtual healthcare systems in Manitoba.
Additionally, strong presence of major market players such as Veradigm LLC, Edifecs, and others is also creating a notable impetus for regional growth. In fact, in October 2022, Veradigm LLC, an American publicly traded IT firm, made Carequality, which is a non-profit interoperability framework available in the U.S. with Veradigm EHR.
Healthcare Data Interoperability Market Share
Some of the major healthcare data interoperability industry players are:
These firms are majorly turning to strategic partnerships to gain a competitive advantage. Citing an instance, in January 2022, Epic Systems Corporation, an American healthcare software firm, inked a deal with Priority Health, a Michigan-based health plan provider, for streamlining its patient data flow.
This partnership helped the company minimize costs, improve patient experience and population health, and enhance the healthcare workflow. It also helped it expand its customer base while maximizing revenue.
Impact of COVID-19 pandemic
The COVID-19 pandemic had a moderate impact on healthcare data interoperability industry as it led to skyrocketing demand for digital solutions such as EHR software for healthcare data interoperability. In fact, many governments across developed and developing nations rolled out regulations for the use of healthcare data interoperability solutions. In August 2020, the Prime Minister of India launched the National Digital Health Mission (presently Ayushman Bharat Digital Mission) for the development of digital health ecosystem.
The healthcare data interoperability market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Level
By Deployment
By Application
By Model
By End-use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →